跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DARPins
首页
药物
DARPins
DARPins
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Capping modules for designed ankyrin repeat proteins
US 9221892 B2
申请人: BINZ HANS KASPAR
优先权: 2010
CN
US
WO
8 件公开
IN VITRO AND IN VIVO GENE DELIVERY TO IMMUNE EFFECTOR CELLS USING NANOPARTICLES FUNCTIONALIZED WITH DESIGNED ANKYRIN REPEAT PROTEINS (DARPINS)
US 2023049655 A1
申请人: BIONTECH CELL & GENE THERAPIES GMBH
优先权: 2019
CN
EP
US
WO
5 件公开
DARPINS FOR USE IN REDUCING RENAL ACCUMULATION OF DRUGS
EP 4673159 A1
申请人: MOLECULAR PARTNERS AG
优先权: 2023
EP
US
WO
3 件公开
Bispecific chimeric proteins comprising DARPins
US 9359440 B2
申请人: SAMSUNG ELECTRONICS CO LTD
优先权: 2013
US
2 件公开
Anti-EGFR/anti-HER2 bispecific antibodies with anti-EGFR DARPins
US 9499622 B2
申请人: SAMSUNG ELECTRONICS CO LTD
优先权: 2014
US
Methods for allergy diagnosis
US 11035863 B2
申请人: IMMUNOVENT LLC
优先权: 2016
US
DUAL INHIBITION OF PLEXIN-B1 AND PLEXIN-B2
EP 3693380 A1
申请人: MAX PLANCK GESELLSCHAFT
优先权: 2019
EP
Highly modular biepitopic and bispecific CAR-T cells for cancer immunotherapy
US 12410260 B2
申请人: UNIV NORTH CAROLINA CHAPEL HILL
优先权: 2020
US
DARPin reagents that distinguish Alzheimer's disease and Parkinson's disease samples
US 11300576 B2
申请人: UNIV ARIZONA STATE
优先权: 2020
US
TARGETED DELIVERY VEHICLES FOR ENDOGENOUS CELL ENGINEERING
WO 2025090583 A1
申请人: UNIV CALIFORNIA
优先权: 2023
WO
第 1 / 2 页
上一页
下一页
药物
反馈